Submissions are open for the upcoming issue.

Molecular Medicine Peer-reviewed scientific journal

Found: 33

ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2016

POLYMORPHISM ANALYSIS OF THE ACTA2 GENE BY PYROSEQUENCING IN PATIENTS WITH NON-FAMILIAL THORACIC AORTIC ANEURYSMS

Introduction. The ACTA2 gene encodes α-actin in aortic smooth muscle cells, and its mutations may cause thoracic aortic aneurysms. Analysis of ACTA2 polymorphism can be used in a complex risk assessment of non-familial thoracic aortic aneurysms. The aim of the…

Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2015

ТР53 GENE MUTATIONS AND THEIR PROGNOSTIC SIGNIFICANCE IN BLADDER CANCER

Introduction. Mutations in the tumor suppressor gene TP53 are observed approximately in the half of all human malignancies. In bladder cancer (BC), ТР53 molecular alterations were shown to be associated with more aggressive tumor phenotype; however their clini…

Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2015

SOMATIC AND GERMLINE MUTATIONS IN GASTRIC CANCER

Introduction. Most cases of gastric cancer (GC) occur sporadically. Until recently, diffuse hereditary gastric cancer associated with the CDH1 gene mutations was considered the only hereditary form (about 1–3% of all tumors of the stomach). However, a signific…

Details ↗
Research article2014

APPLICATION OF NGS METHOD FOR ACVR2A GENE SEQUENCING IN WOMEN WITH PREECLAMPSIA

Introduction. Preeclampsia is one of the most frequent complications of pregnancy. Disease is based on the pathology of the vascular system of a pregnant woman. One of the candidate genes of preeclampsia is a gene encoding a protein receptor type 2A to activin…

Details ↗
Research article2014

SEVERAL GENETIC FEATURES OF HUMAN METASTATIC CUTANEOUS MELANOMA

Introduction. The prevalence of human cutaneous melanoma (CM) in the world is constantly rising. Diagnostics and treatment of CM at the early stages allows to increase the 5-year patient survival up to 90%. This problem can be solved with personalized therapy …

Details ↗
Research article2014

THE MYH7, MYBPC3 GENE MUTATIONS IN HYPERTROPHIC CARDIOMYOPATHY PATIENTS RESIDING IN THE REPUBLIC OF BELARUS

Introduction. Hypertrophic cardiomyopathy (HCM) is a common genetically heterogeneous disease caused by mutations in genes encoding proteins of the cardiac sarcomere. Mutations in the genes encoding β-myosin heavy chain (MYH7) and myosin binding protein C (MYB…

Details ↗

Article search and quick navigation

Navigation